ArticleBMC cancer2020

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial.

Changjun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.